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The effect of rat synthetic atria1 natriuretic factor (ANF) on adenylate cyclase activity was studied in adrenal 
cortical membranes. Synthetic ANF (Arg lOl-Tyr 126) inhibited adenylate cyclase activity in a concentra- 
tion-dependent manner. The maximum inhibition observed was about 25% with an apparent k, of 5 x lo-l1 
to 10mro M. Various hormones such as isoproterenol, dopamine, prostaglandin (PGE,) and ACTH-stimulat- 
ed adenylate cyclase 40 various degrees and ANF inhibited the stimulatory effect of all these hormones to 
some degree but never abolished it. In addition, ANF was also able to inhibit the stimulation exerted by 
forskolin which activates adenylate cyclase by receptor-independent mechanism. This is the first study de- 
monstrating the inhibitory effect of ANF on adrenal cortical adenylate cyclase. From these results it can 
be suggested that the inhibition of adenylate cyclase may be one of the mechanisms through which ANF 
exerts the inhibitory effect on steroidogenesis stimulated by various hormones and agents. 
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1. INTRODUCTION 
Mammalian atria have been shown to contain a 
factor that exhibits diuretic and natriuretic activi- 
ty. This factor has been called atria1 natriuretic 
factor [ 11. The atria1 natriuretic factor was also 
shown to exert vasodilatory and vasorelaxant ef- 
fects [2-41. The purification and amino acid se- 
quence of atria1 natriuretic factor has been 
reported by several groups of investigators [5-81. 
Very recently we reported that synthetic atria1 
natriuretic factor inhibits adenylate cyclase ac- 
tivities in heart, vascular smooth muscle from aor- 
ta, mesenteric artery and renal artery [9], anterior 
and posterior pituitary [lo] but not in non-target 
tissues such as spleen, skeletal muscle, testis and 
adrenal medulla [9]. ANF has also been shown to 
inhibit steroidogenesis timulated by angiotensin, 
prostaglandin, ACTH and forskolin [ll] and 
angiotensin II and ACTH [ 121 in zona glomerulosa 
cells. Since the steroidogenesis stimulated by pro- 
staglandins, ACTH and forskolin has been shown 
to be a cyclic AMP-dependent phenomenon, it is 
possible that the inhibitory effect of ANF on 
steroidogenesis stimulated by these agents [1 I] may 
be mediated through the inhibition of adenylate 
cyclase. The present studies were therefore under- 
taken to investigate the effects of ANF on 
adenylate cyclase activity in the presence of various 
stimulators which have been shown to influence 
steroidogenesis. 
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2. MATERIALS AND METHODS 
2.1. Materials 
Abbreviations: ANF, rat synthetic atrial natriuretic fac- 
tor (Arg lOl-Tyr 126); PGEr, prostaglandin; ACTH, 
adrenocorticotropic hormone; FSK, forskolin 
GTP, ATP, cyclic AMP, isoproterenol and 
dopamine were purchased from Sigma (St. Louis, 
MO). Creatine kinase (EC 2.7.3.2) and myokinase 
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(EC 2.7.4.3) were purchased from Boehringer 
Mannheim, Canada.. [cx-~*P]ATP was purchased 
from Amersham. ACTH was from Penninsula and 
forskolin was obtained from Calbiochem-Behring 
Corp. (San Diego, CA). Synthetic rat atria1 
natriuretic factor (Arg lOl-Tyr 126) was a gift 
from Dr R. Nutt of Merck, Sharp & Dohme 
Research Laboratories. 
2.2. Preparation of adrenal cortical membranes 
Adrenal glands were dissected out from Sprague 
Dawley rats (200-300 g). The capsular zone (zona 
glomerulosa) was separated from the subcapsular 
area (zona fasciculata) and was homogenized using 
a teflon-glass homogenizer in a buffer containing 
10 mM Tris and 1 mM EDTA (pH 7.5). The 
homogenate was centrifuged at 20000 x g for 
10 min. The supernatant was discarded and the 
pellet was homogenized in the above buffer with a 
glass-teflon homogenizer. This preparation was 
used for adenylate cyclase determination. 
2.3. Adenylate cyclase activity determination 
Adenylate cyclase activity was determined by 
measuring [32P]cAMP formation from [32P]ATP 
as in [9,13]. Typical assay medium contained 
50 mM glycylglycine (pH 7.5), 0.5 mM MgATP, 
[w~*P]ATP (l-l .5 x lo6 cpm), 5 mM MgCl2 (in 
excess of the ATP concentration, 0.5 mM CAMP, 
10pM GTP and ATP regenerating system con- 
sisting of 2 mM creatine phosphate, 0.1 mg 
creatine kinase per ml, and 0.1 mg myokinase per 
ml in a final volume of 200 ~1. Incubations were in- 
itiated by the addition of the membranes 
(50-1OOpg) to the reaction mixture which had 
been thermally equilibrated for 2 min at 37°C. In- 
cubations were conducted in triplicate for 10 min 
at 37°C. Reactions were terminated by the addi- 
tion of 0.6 ml of 120 mM zinc acetate. CAMP was 
purified by co-precipitation of other nucleotides 
with ZnCOs by the addition of 0.5 ml of 144 mM 
Na2CO3 and subsequent chromatography by the 
double column system as described by Salomon et 
al. [14]. Under the assay conditions used, 
adenylate cyclase activity was linear with respect to 
protein concentration and time of incubation. 
Protein was determined essentially as described 
by Lowry et al. [15] with crystalline bovine serum 
albumin as standard. 
3. RESULTS 
Fig. 1 shows the effect of various concentrations 
of synthetic rat ANF on adenylate cyclase activity 
in rat adrenal cortical membranes. ANF inhibited 
adenylate cyclase activity in a concentration- 
dependent manner with an apparent K, between 
0.05 to 0.1 nM. The maximal inhibition observed 
was about 25%. A similar inhibitory effect of ANF 
was also observed on adenylate cyclase in bovine 
adrenal cortical membranes from zona glomeru- 
losa cells and bovine cultured zona glomerulosa 
cells (not shown). These data suggest the presence 
of ANF receptors in adrenal cortex which are 
negatively coupled to adenylate cyclase. 
Various hormones have been shown to stimulate 
adenylate cyclase and steroidogenesis in adrenal 
cortex [16]. Recently it was shown that ACTH-, 
prostaglandin- and forskolin-stimulated steroido- 
genesis in cultured bovine zona glomerulosa cells 
was significantly inhibited by ANF [ 111. Since all 
these agents also stimulate adenylate cyclase, it is 
possible that the inhibitory effect of ANF on ste- 
roidogenesis may be mediated through the adenyl- 
ate cyclase/cAMP system, we were tempted to in- 
ANF (M) 
Fig.1. Effect of various concentrations of ANF on 
adenylate cyclase activity in adrenal cortical membranes. 
Adenylate cyclase activity was determined as in section 
2. Values are means of triplicate determinations from 
one of three different experiments. 
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Fig.2. Effect of ANF on basal or stimulated adenylate 
one of three different experiments. 
cyclase activity by various agonists in adrenal cortical 
membranes. Adenylate cyclase activity was determined 
in the absence or presence of 1 PM prostaglandin 
(PGEt), 50 PM isoproterenol (ISO), 100 PM dopamine 
(DA), 50pM forskolin (FSK) alone (0) or in 
combination with 10 nM ANF (a) as in section 2. 
Values are means + SE of triplicate determinations from 
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Fig.3. Effect of various concentrations of 
adrenocorticotropic hormone (ACTH) on adenylate 
cyclase activity in adrenal cortical membranes in the 
absence (W---O), or presence of 10 nM ANF (C+-O). 
Adenylate cyclase activity was determined as in section 
2. Values are means f SE of triplicate determinations 
from one of two different experiments. 
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Fig.4. Effect of various concentrations of isoproterenol 
on adenylate cyclase activity in adrenal cortical 
experiments. 
membranes in the absence (M), or presence of 
10 nM ANF (m). Adenylate cyclase activity was 
determined as in section 2. Values are means * SE of 
triplicate determinations from one of two different 
vestigate the effect of ANF on hormone-responsive 
adenylate cyclase activities. The results are shown 
in fig.2. Prostaglandin (PGEr), isoproterenol, 
dopamine and forskolin all stimulated adenylate 
cyclase to various degrees and ANF inhibited the 
stimulatory responses of all these agonists. In no 
case, however, was a complete inhibition observed. 
The effect of ANF was also studied on the entire 
dose-response curve of ACTH-sensitive adenylate 
cyclase activity. As shown in fig.3, ACTH 
stimulated adenylate cyclase activity in a 
concentration-dependent manner, the maximal 
stimulation being observed at 1 PM, and ANF in- 
hibited the stimulatory effect of ACTH on 
adenylate cyclase at all the concentrations used in 
the present studies. 
Similar results were also obtained when the ef- 
fect of ANF was studied on the entire concentra- 
tion curve of isoproterenol (fig.4). The inhibitory 
effects of ANF on ACTH-, and isoproterenol- 
stimulated adenylate cyclase activities appear to be 
associated with a decrease in I’,,,,, and not an in- 
crease in Ka. 
201 
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4. DISCUSSION REFERENCES 
The data presented emonstrate the presence of 
ANF receptors coupled to adenylate cyclase in 
adrenal cortex. The inhibition of adenylate cyclase 
by ANF suggests that ANF receptors are negatively 
coupled to adenylate cyclase in adrenal cortex. The 
similar inhibition of adenylate cyclase by ANF has 
also been reported previously in target tissues such 
as heart, vascular smooth muscle [9], and anterior 
and posterior pituitary [lo]. The apparent K, 
observed in the present studies (5 x 
10-ll-lO-lo M) is comparable with the values 
observed with the other tissues [9,10]. The in- 
hibitory effect of ANF on basal and PGEi-, 
ACTH- and FSK-stimulated adenylate cyclase is 
interesting and could explain the ability of ANF to 
inhibit steroid secretion stimulated by these agents. 
However, the inhibitory effect of ANF on 
angiotensin II-stimulated steroidogenesis [11,121 
which does not appear to involve CAMP, cannot be 
explained by the above-mentioned mechanism, 
because angiotensin II has been shown to inhibit 
adenylate cyclase activity [ 17,181. The possible 
mechanism(s) by which ANF exerts its inhibitory 
effect on angiotensin II-stimulated steroidogenesis 
may involve calcium movements, phosphatidyl in- 
ositol turnover or cGMP. Nevertheless, the present 
studies indicate that ANF inhibits basal and 
hormone-stimulated adenylate cyclase activities in 
adrenal cortical membranes, and suggest hat in- 
hibition of adenylate cyclase by ANF may be one 
of the mechanisms involved in the inhibition of 
steroid production. 
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